Human trials of a potential coronavirus vaccine developed by researchers at the University of Oxford began late on Thursday, British Health Secretary Matt Hancock announced.
The UK government Health Secretary Matt Hancock pledged £20 million in government funding to support Oxford University’s ChAdOx1 nCoV-19 coronavirus vaccine program, and another £22.5 million to fund Phase II testing of a coronavirus vaccine in development by Imperial College London, which is projected to start human testing in June.
“After all, the upside of being the first country in the world to develop a successful vaccine is so huge that I am throwing everything at it,” Hancock said.
Volunteers in the UK are being offered £625 to take part in the landmark research. COVID-19 vaccine of the coronavirus to be tested on volunteers aged between 18 and 55 who are in a good health.